Oral Health Surgery
Conditions
Interventions
Bilateral Suprazygomatic Maxillary nerve block
Palatine Nerve Block
Sponsors
Research Grant
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria. Inclusion criteria would include 1. All patients with non-syndromic unilateral cleft palate with or without cleft lip. 2. All patients with non-syndromic bilateral cleft palate with or without cleft lip. 3. All patients with cleft palate only. 4. Patients scheduled for secondary palatorraphy. 5. Children with cleft lip and palate between the age of 12 months to 5 years. 6. Patients certified fit for cleft palate repair by the anaesthesiologists with American Society of Anaesthiologists (ASA) I-II 7. All guardians who consent for their wards to be included in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with a medical history suggestive of allergy to bupivacaine. 2. Patients with the presence of coagulation disorders, peripheral neuropathy or chronic pain syndrome, local infection or presence of a lesion or neoplasm around the injection site, chronic rhinorrhea with acute exacerbation and obstructive upper airway disease. 3. Patients with systemic disease that compromises the cardiovascular, respiratory, or neurological function as well as other congenital anomalies. 4. Patients with atypical facial clefts and syndromic clefts. 5. Patients scheduled for palatal fistula repair. 6. Patients whose parents/guardians do not consent to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The duration of analgesia will be assessed following the administration of the suprazygomatic maxillary nerve block in the experimental group and palatine nerve block in the control group using Faces, Legs, Activity, Crying and Consolability pain assessment tool- FLACC pain assessment tool. Pain scores higher than 3 would be assessed as moderate pain and would mark the end of the duration of the analgesia.;The quality of pain control would be assessed following the administration of the suprazygomatic maxillary nerve block in the experimental group and the palatine nerve block in the control block using the FLACC pain assessment tool. Score 0 being no pain and scores 1-3 being mild pain scores. | — |
Secondary
| Measure | Time frame |
|---|---|
| The duration of the administration of analgesia in both groups would be assessed using a timer to assess how long it takes to administer the analgesia in both groups | — |
Countries
Nigeria
Contacts
Public ContactRacheal Babayomi
Senior Registrar Oral and Maxillofacial Surgery
Outcome results
None listed